Please review the September 14th 2022 COPE accredited webinar below as Dr. Clara Chan presented to 400+ ODs nationally on the New Clinical Evidence for Thealoz Duo and Thealoz Duo Gel which is supported by the ASCRS Guidelines (co-authored by Dr. Chan) to Treat Ocular Surface Disease for Cataract and Refractive Surgery with aggressive use of Preservative-Free Artificial Tears to optimize surgical outcomes and improve patient satisfaction.
Labtician Théa is committed to eye care education. Contact us for upcoming COPE accredited webinars.
Program Objectives
- Learn about the science associated with Trehalose and its impact on Ocular Surface
- Evaluate how Trehalose stabilizes tear film thickness, reduces inflammatory markers, restores osmotic balance and reduces dry eye symptoms
- Review new evidence in pre and post-operative surgical use of Trehalose to optimize patient outcomes
- Learn about complex dry eye patient cases from OD peers
Dr Clara Chan, MD, FRCSC, FACS, DABO
Dr. Chan graduated at Stanford University and completed her medical degree at Queen’s University. She attended University of Toronto for her residency and completed her fellowship in Cornea, Anterior Segment and Refractive surgery at Cincinnati Eye Institute Ohio.
Relieve dry eyes with the bioprotection and osmoregulation of Thealoz® Duo. Preservative- and phosphate-free, Thealoz® Duo is a unique dry eye treatment that restores the eye’s normal environment by combining the bioprotective properties of trehalose and the moisturizing effect of sodium hyaluronate.
